Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population
- PMID: 28002458
- PMCID: PMC5176306
- DOI: 10.1371/journal.pone.0168649
Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population
Abstract
Chronic HCV infection, a highly endemic disease in Egypt, is usually asymptomatic for decades after infection. Prediction questionnaire tool was proofed to be a valuable, feasible and efficient instrument for the screening of several diseases. We previously developed an Egyptian HCV risk screening tool (EGCRISC). This study aims to validate/modify EGCRISC. A cross-sectional study testing 4579 individuals by EGCRISC as well as ELISA/PCR was performed. The sample was a stratified cluster sampling from urban and rural areas in Upper and Lower Egypt using a proportional allocation technique. The degree of agreement and positive and negative posttest probabilities were calculated. ROC curve was done and the cutoff points were customized for best performance. The total score was further classified into three levels according to the risk load. The mean age of the participants was 41.1±12.2 in whom HCV prevalence was 8.6%. EGCRISC, particularly after modifying the cutoff points, has a good discriminating ability. The degree of agreement was at least 68.1% and the positive posttest probability ranged from 5% to 37.2% whereas the negative posttest probability was in the range 1% to 17%. We conclude that EGCRISC is a valid tool that can potentially screen for HCV infection risk in Egypt and could diminish the demand for mass serologic screening in those apparently at minimal risk. Extensive use of electronic and self- or interviewer-administered risk-based screening strategy may simplify and promote overall screening and detection of HCV dissimilar communities.
Conflict of interest statement
All authors declare that they have no conflict of interest.
Figures


Similar articles
-
Performance and modification of EGCRISC among hepatitis C virus high-risk groups.Epidemiol Infect. 2020 Feb 14;148:e28. doi: 10.1017/S0950268820000175. Epidemiol Infect. 2020. PMID: 32054561 Free PMC article.
-
Cost-effectiveness of EGCRISC application versus hepatitis C virus mass screening in Egypt.J Infect Public Health. 2019 May-Jun;12(3):442-444. doi: 10.1016/j.jiph.2018.08.004. Epub 2018 Sep 13. J Infect Public Health. 2019. PMID: 30220579
-
Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.Transfusion. 2015 Jun;55(6):1186-94. doi: 10.1111/trf.13061. Epub 2015 Mar 13. Transfusion. 2015. PMID: 25766141
-
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.World J Gastroenterol. 2018 Oct 14;24(38):4330-4340. doi: 10.3748/wjg.v24.i38.4330. World J Gastroenterol. 2018. PMID: 30344418 Free PMC article. Review.
-
HCV in Egypt, prevention, treatment and key barriers to elimination.Expert Rev Anti Infect Ther. 2018 Apr;16(4):345-350. doi: 10.1080/14787210.2018.1448709. Epub 2018 Mar 11. Expert Rev Anti Infect Ther. 2018. PMID: 29506418 Review.
Cited by
-
Validation of discharge diagnosis codes to identify serious infections among middle age and older adults.BMJ Open. 2018 Jun 19;8(6):e020857. doi: 10.1136/bmjopen-2017-020857. BMJ Open. 2018. PMID: 29921683 Free PMC article.
-
Risk Assessment Tools from the One Health Perspective: A Narrative Review.Risk Manag Healthc Policy. 2024 Apr 16;17:955-972. doi: 10.2147/RMHP.S436385. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 38645899 Free PMC article. Review.
-
Performance and modification of EGCRISC among hepatitis C virus high-risk groups.Epidemiol Infect. 2020 Feb 14;148:e28. doi: 10.1017/S0950268820000175. Epidemiol Infect. 2020. PMID: 32054561 Free PMC article.
-
Geospatial epidemiology of hepatitis C infection in Egypt 2017 by governorate.Heliyon. 2019 Aug 17;5(8):e02249. doi: 10.1016/j.heliyon.2019.e02249. eCollection 2019 Aug. Heliyon. 2019. PMID: 31463388 Free PMC article.
References
-
- National Committee for the Control of Viral Hepatitis. Egyptian national control strategy for viral hepatitis 2008–2012 Ministry of Health and Population Available at: www.eiprorg/sites/default/files/pdf/hcv_treatment_in_egyptpdf. 2008.
-
- Wand H, Iversen J, Wilson D, Topp L, Maher L. Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection. BMJ Open. 2012;2(1):e000387 Epub 2012/01/06. bmjopen-2011-000387 [pii]. PubMed Central PMCID: PMC3253425. 10.1136/bmjopen-2011-000387 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical